TORONTO and DUREN, Germany, Sept. 27,
2022 /CNW/ - GBLT Corp. (TSXV: GBLT)
("GBLT" or the "Company") is pleased to announce the
expansion of their operations to the UK market with the opening of
a new sales and marketing office in London, England. The expansion into the UK is
a key milestone in GBLT's global expansion plans and will help
further increase the presence and of the Company's portable energy
and Dr. Senst Personal Healthcare brand.
"We continue to focus on scaling our high margin product lines
and we are pleased to be opening a local office in London headed by a new International Sales
Director to further expand the Company's presence globally," said
Dr. Senst, CEO of GBLT. "The new office in London allows us to continue to expand our
presence past the European mainland and grow a greater presence in
the network of Commonwealth countries, Scandinavia, and other
emerging nations. London
reputation as a global centre for trade and business thanks to its
time zone and flight connections out of Heathrow – one of the world's busiest
international hubs. The expansion into the UK market further
contributes to GBLT's plan to expand its brand presence into other
continents like North America. We
remain excited on the continuous activities GBLT has been fortunate
enough to experience despite the economic volatility in
Europe. We are confident that the
Company will continue to scale globally and continue to capitalize
on our growth opportunities despite today's highly volatile
economic environment."
About GBLT:
GBLT Corp., through its operating company, GBT GmbH, designs,
manufactures and supplies mobile storage, and battery solutions.
GBLT is also a leading provider of renewable energy solutions via
its solar division, participating in the rapidly growing solar
energy market. In addition, the Company offers consumer healthcare
and wellness products to some of the largest retail chains across
the globe. GBT is also an official licensee for AGFAPHOTO mobile
energy products. The Company's branded healthcare and wellbeing
products are primarily sold throughout Europe under Dr. Senst brand.
For more information, please visit www.gbt-international.com
and www.gbltcorp.com.
Forward-Looking
Information
Certain statements in this news release, which are not
historical in nature, constitute "forward looking statements"
within the meaning of that phrase under applicable Canadian
securities law. These statements include, but are not limited to,
statements or information concerning the Company's proposed
activities under the Agreement, the Company's ability to achieve
sales, commercial or otherwise, from its products, and the
expectations of the Company regarding funding payments due pursuant
to the Agreement. These statements reflect management's current
assumptions and expectations and by their nature are subject to
certain underlying assumptions, known and unknown risks and
uncertainties and other factors which may cause actual results,
performance or events to be materially different from those
expressed or implied by such forward looking statements. Except as
required pursuant to applicable securities laws, the Company will
not update these forward-looking statements to reflect events or
circumstances after the date hereof. More detailed information
about potential factors that could affect financial results is
included in the documents filed from time to time with the Canadian
securities regulatory authorities by the Company. Readers are
cautioned not to place undue reliance on forward looking
statements.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
SOURCE GBLT Corp.